Marco Strub
Net worth: 74 653 $ as of 2026-05-30
Net worth: 74 653 $ as of 2026-05-30
Marco Andres Strub currently works at Sircon AG, as Chief Executive Officer & Principal from 2003, ZincX Resources Corp., as Independent Director from 2004, Triumph Gold Corp., as Independent Director from 2011, TAAL Distributed Information Technologies, Inc., as Independent Director from 2018, Clarrence AG, as Director, KOP Therapeutics Corp., as Director, E3 Lithium Ltd., as Director from 2011, and Riverside Resources, Inc., as Independent Director from 2026.
Mr. Strub also formerly worked at E3 Lithium Ltd., as Director from 2011 to 2012, MVE Capital Corp., as Director from 2007 to 2011, Vault Strategic Mining Corp., as Independent Director from 2011 to 2014, Open Gold Corp., as Independent Director, Vault Strategic Mining Corp., as Director from 2011 to 2014, and Exulta AG, as Partner from 1997 to 2003.
Mr. Strub received his graduate degree in 1982 from the University of St. Gallen and Masters Business Admin degree from the University of St. Gallen.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TRIUMPH GOLD CORP. 0.22% | 2025-05-11 | 135,600 ( 0.22% ) | 52 613 $ | 2026-05-30 |
| 2025-03-03 | 380,000 ( 0.2% ) | 22 040 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| ZINCX RESOURCES CORP. | Director/Board Member | 2004-10-31 |
| TRIUMPH GOLD CORP. | Director/Board Member | 2011-05-08 |
| TAAL DISTRIBUTED INFORMATION TECHNOLOGIES INC. | Director/Board Member | 2018-10-24 |
| RIVERSIDE RESOURCES INC. | Director/Board Member | 2026-06-16 |
| E3 LITHIUM LIMITED | Director/Board Member | 2010-12-31 |
Sircon AG | Chief Executive Officer | 2003-02-28 |
Clarrence AG
Clarrence AG Investment ManagersFinance Provides investment services | Director/Board Member | - |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology Develops genomic drug platform for cancer | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| VAULT STRATEGIC MINING CORP. | Director/Board Member | 2014-04-22 |
| ░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 13 |
|---|---|
E3 Lithium Ltd.
E3 Lithium Ltd. Chemicals: SpecialtyProcess Industries Explores and develops lithium projects | Process Industries |
ZincX Resources Corp.
ZincX Resources Corp. Other Metals/MineralsNon-Energy Minerals Engages in the exploration and development of mineral properties | Non-Energy Minerals |
Triumph Gold Corp.
Triumph Gold Corp. Precious MetalsNon-Energy Minerals Explores mineral resources | Non-Energy Minerals |
MVE Capital Corp.
MVE Capital Corp. Financial ConglomeratesFinance Capital pool company | Finance |
Riverside Resources, Inc.
Riverside Resources, Inc. Precious MetalsNon-Energy Minerals Engages in the acquisition, exploration and development of mineral properties | Non-Energy Minerals |
Vault Strategic Mining Corp.
Vault Strategic Mining Corp. Other Metals/MineralsNon-Energy Minerals Engages in mining diamonds | Non-Energy Minerals |
TAAL Distributed Information Technologies, Inc.
TAAL Distributed Information Technologies, Inc. Data Processing ServicesTechnology Services Operates as a blockchain service provider | Technology Services |
University of St. Gallen
University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exulta AG | |
Sircon AG | |
Open Gold Corp.
Open Gold Corp. Precious MetalsNon-Energy Minerals Engages in the exploration and development gold, copper and silver mines | Non-Energy Minerals |
Clarrence AG
Clarrence AG Investment ManagersFinance Provides investment services | Finance |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology Develops genomic drug platform for cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions